Mitchell Gold, Executive Chairman and CEO at ALPINE IMMUNE SCIENCES, INC. (ALPN), sold 183,768 shares at $20.43 ($3.7M) on 2023-12-22, disclosed to the SEC on 2023-12-27.
Scheduled sale ($3.7M) by Executive Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.43 | 37,825 | $773K | 20.8% |
| 2 | $20.43 | 37,825 | $773K | 20.8% |
| 3 | $20.22 | 24,486 | $495K | 13.3% |
| 4 | $20.22 | 24,486 | $495K | 13.3% |
| 5 | $20.04 | 29,573 | $593K | 15.9% |
| 6 | $20.04 | 29,573 |
| $593K |
| 15.9% |
| Total | $20.25 avg | 183,768 | $3.7M | 100% |
| Filing → |
| ALPN | SELL | 2023-12-12 | $3.5M | — | Filing → |
| ALPN | SELL | 2021-09-21 | $4.7M | — | Filing → |
| ALPN | SELL | 2021-09-17 | $103K | — | Filing → |